Outcome of Adolescents with Acute Lymphoblastic Leukemia Treated by Pediatrics versus Adults Protocols

Table 4

Toxicity profile difference between 2 regimens during induction.

Toxicity	aBFM 90-HR (%)	aBFM standard (%)	value
Neutropenia
GI-II	60	70	0.049
GIII-IV	40	30	0.049
Thrombocytopenia GIV	40	25	0.003
Mucositis GIII-GIV	30	20	0.005
Thrombotic events	7	6	0.010
Liver impairment
Elevated bilirubin	37	20	0.001
Elevated enzyme	28	11	0.003